The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell ...

In this episode of the Ask the Expert video series, Simona Guidi, Associate Director, Cell and Gene Therapies at ProPharma, ...

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

By joining the network, NIBRT, Firefinch, and eg technology gain access to what EIT Health referred to as a pan-European ...

The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 13 medicines for marketing authorization at its June 16–19 meeting (1). Among the authorized medicines ...

BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. as part ...

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 ...

Fabian Gerlinghaus, Alexander Seyf, and Knut Steffensen go behind the headlines and dive into the advanced therapy ecosystem.

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...